Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PDUFA Acronym War Begins: Could Reauthorization Be Called Patient-UFA?

Executive Summary

For first time ever, the administration that negotiated a user fee agreement won’t be shepherding its reauthorization through Congress.

You may also be interested in...



PDUFA VI: Industry Ready For 'Hard Sell' To Keep Agreement Intact

Biopharma industry is preparing for the unwelcome possibility that the new Congress and Trump Administration will seek to revisit provisions in the negotiated agreement for the US FDA user fee program's reauthorization.

21st Century Cures Revisions Tell FDA To Highlight ‘Patient Experience Data’

Lame-duck passage is goal of changes to reform legislation, which now includes highly targeted funding for FDA.

21st Century Cures Revisions Tell FDA To Highlight ‘Patient Experience Data’

Lame-duck passage is goal of changes to reform legislation, which now includes highly targeted funding for FDA.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS119522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel